{{Rsnum
|rsid=1697144
|Gene=CD180
|Chromosome=5
|position=67184176
|Orientation=minus
|ReferenceAllele=A
|MissenseAllele=G
|GMAF=0.007346
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=CD180
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 0.0 | 0.0 | 100.0
| HCB | 0.0 | 2.2 | 97.8
| JPT | 0.0 | 15.9 | 84.1
| YRI | 0.0 | 0.0 | 100.0
| ASW | 0.0 | 0.0 | 0.0
| CHB | 0.0 | 2.2 | 97.8
| CHD | 0.0 | 0.9 | 99.1
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}

{{Venter SNP
|rsid=1697144
|allele=C
|frequency=1
|uid=1103654123610
|type=homozygous_SNP
|hugo=CD180
|ensembl gene=ENSG00000134061
|ensembl transcript=ENST00000256447
|sift=TOLERATED
|disease=Decreased expression of LY64 has been shown in systemic lupus erythematosus (SLE). The loss of LY64 is associated with B- cell activation and increased disease activity in SLE patients.
}}

{{GET Evidence
|gene=CD180
|aa_change=Ile223Val
|aa_change_short=I223V
|impact=not reviewed
|qualified_impact=Insufficiently evaluated not reviewed
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs1697144
|overall_frequency_n=10757
|overall_frequency_d=10758
|overall_frequency=0.999907
|n_genomes=56
|n_genomes_annotated=0
|n_haplomes=112
|n_articles=0
|n_articles_annotated=0
|nblosum100=-4
|autoscore=0
|webscore=N
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}